Core Points - The chairman of Zhejiang Hu-Hang-Yong (00576), Mr. Wu Chenggen, has submitted his resignation due to reaching retirement age [1] - Mr. Wu will step down from his positions as a director, chairman, chairman of the Strategic Development and ESG Committee, and legal representative of the company [1] - After his resignation, Mr. Wu will not hold any positions in the company or its subsidiaries [1]

Core Points - Zhejiang Securities announced the resignation of Chairman Wu Chenggen due to retirement age, effective immediately [1] - The company held its third extraordinary shareholders' meeting of 2025, approving the appointment of Qian Wenhai as the new Chairman and CEO [1] - Qian Wenhai will also serve as the legal representative and chairman of the board's strategic development and ESG committee [1] Company Changes - Wu Chenggen has resigned from all positions within the company and its subsidiaries [1] - Qian Wenhai's appointment as Chairman and CEO was confirmed during the shareholders' meeting [1] - The board of directors previously approved the election of Qian Wenhai as Chairman on October 24, 2025 [1]

证券日报网讯 11月10日晚间，浙商证券发布公告称，浙商证券股份有限公司（以下简称"公司"）于近 日收到公司董事长吴承根先生的书面辞职报告，吴承根先生因到龄退休，申请辞去公司第四届董事会董 事、董事长、董事会战略发展与ESG委员会主席、法定代表人职务，辞任后不在公司及公司控股子公司 担任任何职务。 （文章来源：证券日报） ...

证券日报网讯 11月10日晚间，浙商证券发布公告称，2025年11月10日，公司召开2025年第三次临时股 东会，审议通过公司董事长兼任总裁事项，自股东会当日起，钱文海先生正式履行公司董事长、法定代 表人、董事会战略发展与ESG委员会主席职务，同时兼任公司总裁、代行财务负责人。公司将按照有关 规定尽快办理法定代表人工商变更登记等事项。 （文章来源：证券日报） ...

Macro Dynamics - The State Council issued measures to guide private capital's orderly participation in low-altitude economy infrastructure construction, optimizing satellite communication business access policies and supporting capable private enterprises in major national technology tasks [2] Pharmaceutical Innovations - Shanghai Hepu Pharmaceutical's innovative hepatitis B drug Hepulapta achieved breakthrough results in a Phase II clinical trial, showing the ability to reverse drug resistance in chronic hepatitis B patients and achieve sterilizing cure [3] Automotive Market - In October, the retail sales of new energy passenger vehicles reached 1.282 million units, a year-on-year increase of 7.3%, while the cumulative sales from January to October reached 10.151 million units, growing by 21.9% [4][5] Oil Price Adjustments - Domestic gasoline and diesel prices will increase by 125 and 120 yuan per ton respectively starting from November 10, with an average increase of 0.10 yuan per liter for 92, 95 gasoline, and 0 diesel [6] Monetary Policy - The Bank of Japan's October meeting minutes suggest a possible interest rate hike in December, aligning with market expectations for an increase in borrowing costs by early next year [7] Financial Institutions - Zhejiang Securities announced the retirement of Chairman Wu Chenggen and the appointment of Qian Wenhai as the new chairman and president [9] Market Data - The Shanghai Composite Index rose by 0.53% on November 10, with significant gains in the consumer goods sector, particularly in food and beverage stocks [11] - The total margin financing balance decreased by 50.19 billion yuan as of November 7, with the Shanghai Stock Exchange reporting a balance of 12,567.49 billion yuan [12] Company Developments - Purun Co. announced a share transfer at 106.66 yuan per share, which is a 38% discount compared to the closing price [14] - Zhongji Xuchuang plans to issue H-shares and list on the Hong Kong Stock Exchange [15] - Mindray Medical submitted an application for H-share listing on the Hong Kong Stock Exchange [16] - Shandong Gold's subsidiary needs to pay 738 million yuan in taxes, which is expected to impact the company's net profit for 2025 by 230 million yuan [17] - Lingzhi Software plans to acquire 100% of Kaimiride's equity, with stock resuming trading on November 11 [18] - *ST Yuancheng's stock will be suspended from trading due to falling below the mandatory delisting threshold [19]

Core Viewpoint - Wu Chenggen has resigned from his positions as Chairman and Director of Zheshang Securities due to retirement age, and will not hold any positions in the company or its subsidiaries after resignation [1] Group 1 - Wu Chenggen submitted a written resignation report to Zheshang Securities [1] - He has stepped down from the fourth board of directors, including his roles as Chairman, Chairman of the Strategic Development and ESG Committee, and legal representative [1] - The resignation is effective immediately, and he will not take on any roles within the company or its subsidiaries post-resignation [1]

Core Viewpoint - Zhejiang Huhangyong (00576.HK) announced the resignation of Chairman Wu Chenggen due to retirement, effective immediately, with no further roles in the company or its subsidiaries [1] Group 1: Company Updates - Wu Chenggen has submitted a written resignation report, stepping down from his positions including Chairman and legal representative [1] - As of November 10, 2025, Zhejiang Huhangyong's stock closed at HKD 7.68, reflecting a 1.05% increase with a trading volume of 2.378 million shares and a turnover of HKD 18.22 million [1] - The stock has received a majority "buy" rating from investment banks, with three banks issuing buy ratings in the last 90 days, and a target price averaging HKD 8.25 [1] Group 2: Financial Metrics - Zhejiang Huhangyong's market capitalization is HKD 15.377 billion, ranking second in the highway II industry [2] - Key financial indicators include: - ROE: 12.14%, compared to the industry average of 7.45% [2] - Market capitalization: HKD 15.377 billion, against an industry average of HKD 6.437 billion [2] - Revenue: HKD 18.383 billion, exceeding the industry average of HKD 7.448 billion [2] - Net profit margin: 45.19%, significantly higher than the industry average of 17.45% [2] - Gross margin: 39.62%, compared to the industry average of 36.0% [2] - Debt ratio: 67.87%, lower than the industry average of 70.33% [2]

浙商证券董事长离任公告要点解读 核心要点 人事变动情况： 董事长吴承根因到龄退休，于2025年11月10日辞任 辞去职务包括：董事、董事长、董事会战略发展与ESG委员会主席、法定代表人 无需股东和债权人特别关注的相关事项 该人事变动属正常的年龄退休，对公司治理结构和日常经营无重大不利影响。 离任影响： 辞职未导致董事会低于法定最低人数，不影响董事会正常运作 辞职报告自送达董事会时生效 其他关键信息： 离任原因为正常到龄退休，非因意见分歧或其他异常情况 确认无未履行完毕的公开承诺 辞任后不在公司及控股子公司担任任何职务 ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 人民财讯11月10日电，浙商证券（601878）11月10日公告，吴承根因到龄退休，申请辞去公司董事、董 事长等职务，辞任后不在公司及公司控股子公司担任任何职务。 11月10日，公司召开临时股东会，审议通过公司董事长兼 任总裁事项，自股东会当日起，钱文海正式 履行公司董事长等职务，同时兼任公司总裁、代行财务负责人。 责任编辑：刘万里 SF014 ...

关于公司董事长离任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 二、离任对公司的影响 按照相关法律法规和《公司章程》的规定，吴承根先生的辞职未导致公司董 事会低于法定最低人数要求，不会影响董事会的正常运作,吴承根先生的辞职报 告自送达董事会时生效。 i 证券代码：601878 证券简称：浙商证券 公告编号：2025-067 吴承根先生在担任公司董事长期间，开拓创新、恪尽职守、勤勉尽责，为促 进公司可持续健康发展发挥了重要的积极作用。公司董事会对吴承根先生在公司 任职期间所做出的卓越贡献表示衷心感谢！ 浙商证券股份有限公司 一、离任的基本情况 浙商证券股份有限公司（以下简称"公司"）于近日收到公司董事长吴承根 先生的书面辞职报告，吴承根先生因到龄退休，申请辞去公司第四届董事会董事、 董事长、董事会战略发展与 ESG 委员会主席、法定代表人职务，辞任后不在公司 及公司控股子公司担任任何职务。吴承根先生确认不存在未履行完毕的公开承诺， 与董事会无任何意见分歧，且无任何与辞职有关的事项及任何有必要引起公司股 东和债权人注意的 ...